Exploring Indicators of Vulnerability in Older Adults With Newly Diagnosed Multiple Myeloma

被引：0
|
作者：
Wildes, Tanya M. [1 ]
机构：
[1] Univ Nebraska Med Ctr, Nebraska Med, Omaha, NE 68198 USA
来源：
JCO CLINICAL CANCER INFORMATICS | 2024年 / 8卷
关键词：
CANCER-TREATMENT; SURVIVAL;
D O I：
10.1200/CCI.24.00013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Bortezomib in newly diagnosed multiple myeloma
    James R. Berenson
    Nature Reviews Clinical Oncology, 2009, 6 : 255 - 256
  • [12] Treatment of newly diagnosed multiple myeloma
    Palumbo A.
    Magarotto V.
    Larocca A.
    Bringhen S.
    Falco P.
    Di Raimondo F.
    Baldini L.
    Boccadoro M.
    Current Hematologic Malignancy Reports, 2008, 3 (2) : 107 - 114
  • [13] Bortezomib in newly diagnosed multiple myeloma
    Berenson, James R.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (05) : 255 - 256
  • [14] A comparative analysis of transcriptomics of newly diagnosed multiple myeloma: exploring drug repurposing
    Giannakoulas, Angelos
    Nikolaidis, Marios
    Amoutzias, Grigorios D.
    Giannakoulas, Nikolaos
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [15] Quality of Life Assessment in Older Patients with Newly-Diagnosed Multiple Myeloma
    Mian, Hira
    Fiala, Mark
    Pond, Gregory
    Wildes, Tanya
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E232 - E233
  • [16] Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies
    Fakhri, Bita
    Fiala, Mark A.
    Tuchman, Sascha A.
    Wildes, Tanya M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (03): : 219 - 224
  • [17] Understanding health outcome preferences of older adults diagnosed with multiple myeloma
    Maheshwari, Supriya
    Arias, Miguel
    Ubersax, Clare
    Tucker, Abigail
    Bal, Susan
    Ravi, Gayathri
    Godby, Kelly
    Costa, Luciano J.
    Williams, Grant R.
    Shrestha, Sadeep
    Bhatia, Smita
    Giri, Smith
    JOURNAL OF GERIATRIC ONCOLOGY, 2024, 15 (05)
  • [18] Response Adapted Therapy Using Single Agent Lenalidomide in Older Adults with Newly Diagnosed Standard Risk Multiple Myeloma
    Baz, Rachid
    Alsina, Melissa
    Shain, Kenneth H.
    Paleveda, Jennifer
    Hillgruber, Nancy
    Finley-Oliver, Elizabeth
    Ochoa, Leonel
    Nishihori, Taiga
    Dalton, William
    Sullivan, Daniel
    BLOOD, 2012, 120 (21)
  • [19] Optimising bortezomib in newly diagnosed multiple myeloma
    Rajkumar, S. Vincent
    LANCET ONCOLOGY, 2010, 11 (10): : 909 - 910
  • [20] Oprozomib in patients with newly diagnosed multiple myeloma
    Hari, Parameswaran
    Matous, Jeffrey V.
    Voorhees, Peter M.
    Shain, Kenneth H.
    Obreja, Mihaela
    Frye, John
    Fujii, Hisaki
    Jakubowiak, Andrzej J.
    Rossi, Davide
    Sonneveld, Pieter
    BLOOD CANCER JOURNAL, 2019, 9 (9)
12345